Accel Research Sites Network acquires 2 new locations

Clinical trial leader will now serve Ormond Beach, Edgewater in Florida ORLANDO, Fla.–(BUSINESS WIRE)–Accel Research Sites Network has always been dedicated to bringing innovative treatments to a variety of patients through cutting-edge clinical trials. The company will now be able to serve an even larger population, expanding its community reach. The clinical trial leader announced … [Read more…]

Ironwood Pharmaceuticals to Host First Quarter 2023 Investor Update Call

BOSTON–(BUSINESS WIRE)–Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced it will host its first quarter 2023 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, May 4, 2023. Individuals interested in participating in the call should dial (888) 330-2384 (U.S. and Canada) or (240) 789-2701 (international) using conference ID number and event … [Read more…]

Janux Therapeutics Announces First Patient Dosed with JANX008 in First-in-Human Phase 1 Clinical Trial in Patients with Solid Tumors

SAN DIEGO–(BUSINESS WIRE)–$JANX—Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms, today announced the first patient has been dosed at City of Hope in a Phase 1 clinical … [Read more…]

Establishment Labs Notes Presentation of 3-Year Results from Motiva U.S. IDE Study at The Aesthetic Meeting 2023

NEW YORK–(BUSINESS WIRE)–Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today noted the presentation of a study update on the Motiva US IDE Study. The update included three-year patient follow-up data for primary augmentation subjects. The Medical Director of … [Read more…]

Allonnia Expands Footprint in Seaport District

New office, lab space will advance milestones, increase staff by 50 percent BOSTON–(BUSINESS WIRE)–Allonnia, a startup biotechnology company dedicated to solving the world’s toughest waste challenges, today celebrated the expansion of its footprint in the Seaport District with a celebratory ribbon cutting and grand opening. The event took place at the company’s new offices and … [Read more…]

CORRECTING and REPLACING Quantum Health Joins With HPI and Employers Health Network to Offer New Healthcare Navigation and High-Performance Networks Platform to Self-Insured Employers

WESTBOROUGH, Mass. & DUBLIN, Ohio–(BUSINESS WIRE)–Please replace the release with the following corrected version due to multiple revisions. The updated release reads: QUANTUM HEALTH JOINS WITH HPI AND EMPLOYERS HEALTH NETWORK TO OFFER NEW HEALTHCARE NAVIGATION AND HIGH-PERFORMANCE NETWORKS PLATFORM TO SELF-INSURED EMPLOYERS Quantum Health, the leading consumer healthcare navigation and care coordination company, announced … [Read more…]

Long Island University and Omnicell Launch Center for Innovative Medication Management

Strategic Initiative Expected to Enhance Technological Capabilities, Advance the Practice of Pharmacy & Enable Support of Safe Medication Management BROOKLYN, N.Y.–(BUSINESS WIRE)–Long Island University and Omnicell, Inc. (Nasdaq: OMCL) (Omnicell), a leading provider of medication management and adherence tools for health systems and pharmacies, announced the opening of the Center for Innovative Medication Management (CIMM), … [Read more…]

Voya collaborates with America’s VetDogs to help a veteran or first responder in need

Company raising and sponsoring Cooper, a future service dog, as part of the Puppy with a Purpose program NEW YORK–(BUSINESS WIRE)–Voya Financial, Inc. (NYSE: VOYA) announced today that is has joined the Puppy with a Purpose program, in collaboration with America’s VetDogs, to help a puppy become a future service dog for a veteran or … [Read more…]

Aditxt Announces $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

RICHMOND, Va.–(BUSINESS WIRE)–Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the purchase and sale of an aggregate of 1,585,350 shares of … [Read more…]

Paragonix LUNGguard™ System Shown to Reduce Hospital Readmission Rates in Lung Transplant Recipients

GUARDIAN-Lung Registry data presented at the 43rd ISHLT Annual Meeting & Scientific Sessions demonstrates statistically significant reduction in 1-year hospital readmission rates (p=0.018) for lung transplant recipients when utilizing the Paragonix LUNGguard Donor Lung Preservation System when compared to traditional ice storage of lungs1 CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc., the leading organ transplant company, presented … [Read more…]